Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421263 · ClinicalTrials.gov registry record · Phase 1
The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
A Phase 1 study of Religious or Spiritual Problem, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02421263 is a Phase 1 study of Religious or Spiritual Problem that has completed, run by NYU Langone Health. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02421263, a Phase 1 study of Religious or Spiritual Problem, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders. We hypothesize that religious professionals, given their interests, training, and life experience, will be able to make nuanced discriminations of their psilocybin experiences, thus contributing to the scientific understanding of mystical-type experience. As we better characterize the phenomenology of psilocybin-induced mystical experiences, we may apply this knowledge to improve potential treatment studies in the future. A primary objective is to investigate changes in psychological functioning, spirituality, health, well-being, prosocial attitudes and behavior in professional religious leaders that may occur after receiving psilocybin under supportive conditions. A secondary objective is to determine whether participants who report having had the strongest mystical-type effects during psilocybin sessions will show the largest positive changes in the Interim Questionnaire.
Conditions Studied
Interventions
- DRUG Psilocybin
Study Locations (1)
New York
- NYU Langone Medical Center/Tisch Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-06-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02421263
The ClinicalTrials.gov registry entry for NCT02421263 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Religious or Spiritual Problem appearing as the primary indexed condition, and to 1 intervention - of which Psilocybin is the first listed.
NCT02421263 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02421263 about?
NCT02421263 is a clinical study titled "The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals". The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders. We hypothesize that religious professionals, given their interests, training, and life experience, will be able to make nuanced discriminations of their...
What is the current status of trial NCT02421263?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2020-06-05.
What conditions does trial NCT02421263 study?
This clinical trial studies the following conditions: Religious or Spiritual Problem.
What interventions are being tested in trial NCT02421263?
The interventions under investigation include: Psilocybin (DRUG).
Who is sponsoring clinical trial NCT02421263?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02421263 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.